Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2021) 73 PEP7.4 | DOI: 10.1530/endoabs.73.PEP7.4

ECE2021 Presented Eposters Presented ePosters 7: Diabetes, Obesity, Metabolism and Nutrition (8 abstracts)

Predictors of glucagon-like peptide-1 responses following oral glucose tolerance test in 3 ethnic groups of Malaysia

Shiau Chin Chong 1 , Norlela Sukor 1 , Sarah Anne Robert 2 , Kim Fong Ng 3 & Nor Azmi Kamaruddin 1


1The National University of Malaysia Medical Centre, Endocrinology Unit, Kuala Lumpur, Malaysia; 2The National University Of Malaysia Medical Centre, Pharmacy, Kuala Lumpur, Malaysia; 3Hospital Sultanah Aminah, Cardiology, Johor Bahru, Malaysia


Introduction

Glucagon-like peptide-1 (GLP-1) plays an important role in the pathophysiology of type 2 diabetes mellitus (T2DM). However, results from previous studies on the GLP-1 secretory responses in individuals with different glucose tolerance states remain controversial. This may be contributed by the heterogeneous characteristics of the patients recruited.

Aim

To examine whether GLP-1 secretion is affected by any of the demographic or metabolic parameters in 3 ethnic groups of Malaysian cohort.

Methods

In this cross sectional study, 171 subjects consisting of Malays, Chinese and Indians, were divided into normal glucose tolerance (NGT) (n = 57), prediabetes (n = 54) and T2DM (n = 60) after undergoing a 75 g oral glucose tolerance test (OGTT). Plasma total GLP-1 concentrations were measured at 0, 30 and 120 min during OGTT. As an index of GLP-1 secretory response, area under the curve (AUC) of GLP-1 (AUCGLP-1) was calculated by trapezoidal rule. Relationships between parameters were examined by using stepwise multiple linear regression analyses.

Results

Using AUCGLP-1 as a depedent parameter, age, gender, ethnicity, systolic blood pressure (SBP), fasting total cholesterol and fasting triglyceride explained 27% (adjusted r2) of the variation of GLP-1 response following OGTT. There was a strong positive association between increasing age and AUCGLP-1 (B = 44.81, P <0.001). Male had higher GLP-1 response to OGTT than female (B = -881.49, P = 0.043). Ethnicity was a significant determinant of AUCGLP-1 with the Indians exhibiting higher GLP-1 secretion than the Malays (B = 932.23, P = 0.005). AUCGLP-1 was negatively correlated with triglyceride (B = -676.38, P = 0.02). In contrast to our expectation, AUCGLP-1 was positively associated with increased SBP (B = 16.08, P = 0.039) and total cholesterol (B = 571.57, P = 0.031). No association was detected between AUCGLP-1 and body mass index, waist circumference, HbA1c, fasting insulin and fasting glucose.

Conclusions

In Malaysian cohort, older age, male and Indians had higher GLP-1 responses following OGTT. These demographic factors need to be taken into account when studying GLP-1 secretory responses between T2DM patients and healthy controls. Subjects with increased fasting triglyceride level had lower GLP-1 responses. The positive relationship between GLP-1 response and risk factors which increase insulin resistance such as high total cholesterol and increased SBP might involve an adaptive response and require further study.

Volume 73

European Congress of Endocrinology 2021

Online
22 May 2021 - 26 May 2021

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.